Literature DB >> 17592750

Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb.

Anne Vroon1, Benjamin Drukarch, John G J M Bol, Patrick Cras, John J P Brevé, Stuart M Allan, Jane K Relton, Piet V J M Hoogland, Anne-Marie Van Dam.   

Abstract

Neuroinflammation may play a role in the pathogenesis of Parkinson's disease (PD). The present study questioned whether this neuroinflammatory response differs between the olfactory bulb, as an early affected region and the nigrostriatal system. Indeed, increased microgliosis was shown in post-mortem olfactory bulb of PD patients. Also in olfactory bulb of MPTP-treated mice, microgliosis and increased expression of IL-1alpha, IL-1beta and IL-1ra mRNA was observed early after treatment. These observations implicate that neuroinflammation is not restricted to the nigrostriatal system. MPTP-induced microgliosis in striatum and olfactory bulb was reduced in IL-1alpha/beta knockout mice, indicating that IL-1 affects microglia activation. Importantly, MPTP induced differential regulation of IL-1 receptors. mRNA levels of IL-1RI and, to a lesser extent, IL-1RII were increased in striatum. Interestingly, in the olfactory bulb only IL-1RII mRNA was enhanced. We suggest that differential regulation of IL-1 signaling can serve as an important mechanism to modulate neuroinflammatory activity after MPTP treatment and possibly during PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17592750     DOI: 10.1016/j.exger.2007.04.010

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  29 in total

Review 1.  Olfaction in Parkinson's disease and related disorders.

Authors:  Richard L Doty
Journal:  Neurobiol Dis       Date:  2011-12-20       Impact factor: 5.996

Review 2.  Protective Role of Capsaicin in Neurological Disorders: An Overview.

Authors:  Sakshi Tyagi; Nikhila Shekhar; Ajit Kumar Thakur
Journal:  Neurochem Res       Date:  2022-02-12       Impact factor: 3.996

Review 3.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

4.  The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease.

Authors:  Josh M Morganti; Kevin R Nash; Bethany A Grimmig; Sonali Ranjit; Brent Small; Paula C Bickford; Carmelina Gemma
Journal:  J Neurosci       Date:  2012-10-17       Impact factor: 6.167

Review 5.  Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders.

Authors:  Rasoul Ghasemi; Leila Dargahi; Ali Haeri; Maryam Moosavi; Zahurin Mohamed; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2013-01-20       Impact factor: 5.590

Review 6.  Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease.

Authors:  Hironori Yokoyama; Hayato Kuroiwa; Ryohei Yano; Tsutomu Araki
Journal:  Neurol Sci       Date:  2008-10-21       Impact factor: 3.307

Review 7.  The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes.

Authors:  Rituraj Niranjan
Journal:  Mol Neurobiol       Date:  2013-06-20       Impact factor: 5.590

8.  Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.

Authors:  Richard Gordon; Eduardo A Albornoz; Daniel C Christie; Monica R Langley; Vinod Kumar; Susanna Mantovani; Avril A B Robertson; Mark S Butler; Dominic B Rowe; Luke A O'Neill; Anumantha G Kanthasamy; Kate Schroder; Matthew A Cooper; Trent M Woodruff
Journal:  Sci Transl Med       Date:  2018-10-31       Impact factor: 17.956

Review 9.  Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.

Authors:  Yeojin Bang; Juhee Lim; Hyun Jin Choi
Journal:  Arch Pharm Res       Date:  2021-06-19       Impact factor: 4.946

10.  Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease.

Authors:  Isabelle St-Amour; Mélanie Bousquet; Isabelle Paré; Janelle Drouin-Ouellet; Francesca Cicchetti; Renée Bazin; Frédéric Calon
Journal:  J Neuroinflammation       Date:  2012-10-09       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.